aap Implantate AG (LTS:0N5A) Total Operating Expense: €13.64 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0N5A aap Implantate AG LTS:0N5A
32 GF Score
Price €1.59
GF Value €0.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is aap Implantate AG Total Operating Expense?

aap Implantate AG LTS:0N5A 32 Total Operating Expense is €13.64 Mil as of Dec. 2025. GuruFocus rates LTS:0N5A with a GF Score™ of 32/100 and a GF Value™ of €0.95 (Significantly Overvalued). The stock has 4 warning signs investors should review.

aap Implantate AG's Total Operating Expense for the six months ended in Dec. 2025 was €7.51 Mil. aap Implantate AG's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €13.64 Mil.

aap Implantate AG Total Operating Expense Related Terms

aap Implantate AG Total Operating Expense Historical Data

* Premium members only.

The historical data trend for aap Implantate AG's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aap Implantate AG Total Operating Expense Chart

aap Implantate AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.60 13.96 17.03 13.39 13.64

aap Implantate AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 6.03 7.36 6.14 7.51
LTS:0N5A
32GF Score
aap Implantate AG LTS:0N5A
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aap Implantate AG Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €13.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €13.64 Mil mean?
aap Implantate AG (LTS:0N5A) has a Total Operating Expense of €13.64 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on aap Implantate AG and its competitors.
Is aap Implantate AG's Total Operating Expense too high?
aap Implantate AG's current Total Operating Expense is €13.64 Mil. Overall, aap Implantate AG has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's Total Operating Expense compare to ABT and SYK?
aap Implantate AG's Total Operating Expense of €13.64 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on aap Implantate AG and its competitors. aap Implantate AG's current Total Operating Expense is €13.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
Based on GuruFocus' analysis, aap Implantate AG (LTS:0N5A) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.95, compared to a current price of €1.59 — trading 67.4% above its estimated fair value. The current Total Operating Expense is €13.64 Mil. aap Implantate AG's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For aap Implantate AG (LTS:0N5A), the current Total Operating Expense is €13.64 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aap Implantate AG (LTS:0N5A) Overvalued in 2026?

Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued. The current stock price of €1.59 is trading 67.4% above its estimated GF Value™ of €0.95. GuruFocus considers aap Implantate AG to be Significantly Overvalued.

Key valuation signals for LTS:0N5A:

  • Total Operating Expense: €13.64 Mil
  • GF Value™: €0.95 vs. price of €1.59 (67.4% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the LTS:0N5A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aap Implantate AG Business Description

Other Exchanges AAQ1:Germany
Address Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
32GF Score

Get the complete analysis for LTS:0N5A

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59
Price
€0.95
GF Value